19 January 2024
Iconic Labs PLC
("Iconic" or the "Company")
Notice of AGM
Iconic Labs PLC (LSE: ICON) announces that its Annual General Meeting ('AGM') will be held on Tuesday, 13 February 2024 at 12 noon at the offices of RWK Goodman, 69 Carter Lane, London, EC4V 5EQ.
The Notice of AGM has been posted to Shareholders and will be available to view shortly on the Company's website at: https://www.iconiclabs.co.uk/documents/.
Amongst others, a special resolution at the AGM will be proposed seeking the approval of Shareholders to a share capital reorganisation.
For some time, the shares of the Company have been trading at below nominal value of £0.10. The issue of new ordinary shares in the Company at a price which is less than nominal value is prohibited by the UK Companies Act. The Board, therefore, considers it prudent to seek the approval of shareholders to a sub-division and conversion of each existing ordinary share of £0.10 ("Existing Ordinary Shares") into one new ordinary share of £0.0001 (a "New Ordinary Share") and one deferred share of £0.0999 (a "Deferred Share") (each such Deferred Share having no voting or dividend rights and effectively being worthless) in order that the nominal value of a New Ordinary Share is less than the price of a share in the market. This will enable the Company to raise funds in the future by issuing further shares, should the Directors elect to do so. By effecting this share capital reorganisation in this way, the Company's issued share capital remains the same and similarly, the nominal value of a Shareholder's shareholding will remain unchanged.
EXPECTED TIMETABLE OF PRINCIPAL EVENTS
|
|
Publication and posting of the AGM Notice | 19 January 2024 |
Latest time and date for receipt by Registrars of Form of Proxy in respect of the Annual General Meeting | 12 noon on 9 February 2024 |
Annual General Meeting | 12 noon on 13 February 2024 |
Record Date for the Share Capital Reorganisation | 6.00 pm on 13 February 2024 |
Effective Date for the Share Capital Reorganisation | 8.00 am on 14 February 2024 |
- Ends -
For more information, please contact:
Iconic Labs
Brad Taylor, Chief Executive Officer | Tel: +44 (0) 7462 156238 |
Novum Securities Limited David Coffman / Daniel Harris | Tel: +44 (0) 20 7399 9400
|
Yellow Jersey PR Sarah Hollins Annabelle Wills Bessie Elliot
| Tel: +44 (0) 20 3004 9512 iconic@yellowjerseypr.com
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.